A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628
NCT06840925 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2025-02-21
Summary
A phase I clinical trial to evaluate the relative bioavailability of PRAX-628 tablet formulation compared to capsule formulation
Conditions
- Healthy
Interventions
- DRUG
-
PRAX-628
Once daily oral
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Director, Clinical Development · Praxis Precision Medicines
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-24
- Primary Completion
- 2025-05-30
- Completion
- 2025-06-30
- FDA Drug
- Yes
Countries
- Australia
Study Locations
More Related Trials
-
Food Effect Study of CTP-656 in Healthy Male Volunteers
NCT02680249 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654
NCT06389955 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants
NCT06477926 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Food Effect Study of Two Formulations of TAK-906
NCT04831502 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
NCT07226817 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess New Formulations of TEV-56286
NCT06911567 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects
NCT02412449 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants
NCT06006702 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Relative Bioavailability of Two Newly Developed Tablet Formulations (TF2 and iFF)Compared to BI 1060469 TF1 Formulation, Following Oral Administration (Low and High Dose)in Healthy Female Subjects
NCT02438696 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of Pravastatin Sodium 40 mg Tablets Under Fasting Conditions
NCT00834379 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare Pharmacokinetic Property of SYO-1644 Tab. and Nexavar Tab. in Healthy Male Volunteers
NCT03674060 ·Status: COMPLETED ·Phase: PHASE1
-
LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects
NCT01143298 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
NCT02396147 ·Status: COMPLETED ·Phase: PHASE1
-
LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects
NCT01211964 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety
NCT02586363 ·Status: UNKNOWN ·Phase: PHASE1
-
Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers
NCT02182284 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations
NCT02258321 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers
NCT06378684 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants
NCT03482453 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers
NCT02182414 ·Status: COMPLETED ·Phase: PHASE1
-
To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions
NCT06930937 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy Participants
NCT02906813 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants
NCT06061523 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of LY3866288 in Healthy Participants
NCT06641037 ·Status: COMPLETED ·Phase: PHASE1
-
Pravastatin Sodium 80 mg Tablets Under Fasting Conditions
NCT00830258 ·Status: COMPLETED ·Phase: PHASE1